Comprehensive Analysis for Clinically Relevant Oncogenic Driver Mutations in 1131 Consecutive Lung Adenocarcinomas

被引：0
|
作者：
Arcila, M. E. [1 ]
Lau, C. [1 ]
Jhanwar, S. [1 ]
Zakowski, M. F. [1 ]
Kris, M. G. [1 ]
Ladanyi, M. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
LABORATORY INVESTIGATION | 2011年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1721
引用
收藏
页码：404A / 404A
页数：1
相关论文
共 50 条
  • [31] Co-Mutations of Driver Oncogenes in Untreated Primary Lung Adenocarcinomas (ADCs) and Clinical Correlations
    Nguyen, Doreen
    Ao, Minghui
    Askin, Frederic
    Gabrielson, Ed
    Zheng, Gang
    Li, Qing K.
    LABORATORY INVESTIGATION, 2017, 97 : 460A - 460A
  • [32] Co-Mutations of Driver Oncogenes in Untreated Primary Lung Adenocarcinomas (ADCs) and Clinical Correlations
    Nguyen, Doreen
    Ao, Minghui
    Askin, Frederic
    Gabrielson, Ed
    Zheng, Gang
    Li, Qing K.
    MODERN PATHOLOGY, 2017, 30 : 460A - 460A
  • [33] Prevalence of oncogenic driver mutations in Hispanics/Latin patients with lung cancer. A systematic review and meta-analysis
    Parra-Medina, Rafael
    Castaneda-Gonzalez, Juan Pablo
    Montoya, Luisa
    Gomez-Gomez, Maria Paula
    Cabezas, Daniel Clavijo
    Vargas, Merideidy Plazas
    LUNG CANCER, 2023, 185
  • [34] A COMPREHENSIVE ANALYSIS OF MISSENSE MUTATIONS IN SCN1A IN PATIENTS WITH DRAVET SYNDROME IMPROVES INTERPRETATION OF CLINICALLY RELEVANT VARIANTS
    Coelho Gonsales, M.
    Montenegro, M. A.
    Guerreiro, M. M.
    Coan, A. C.
    Paiva Quast, M.
    Carvalho, S. B.
    Lopes-Cendes, I.
    EPILEPSIA, 2017, 58 : S29 - S30
  • [35] Biological and clinical significance of KRAS mutations in lung cancer: an oncogenic driver that contrasts with EGFR mutation
    Suda, Kenichi
    Tomizawa, Kenji
    Mitsudomi, Tetsuya
    CANCER AND METASTASIS REVIEWS, 2010, 29 (01) : 49 - 60
  • [36] Biological and clinical significance of KRAS mutations in lung cancer: an oncogenic driver that contrasts with EGFR mutation
    Kenichi Suda
    Kenji Tomizawa
    Tetsuya Mitsudomi
    Cancer and Metastasis Reviews, 2010, 29 : 49 - 60
  • [37] Oncogenic driver mutations in non-small cell lung cancer: Past, present and future
    Chevallier, Mathieu
    Borgeaud, Maxime
    Addeo, Alfredo
    Friedlaender, Alex
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2021, 12 (04): : 217 - 237
  • [38] Molecular Epidemiology of EGFR and KRAS Mutations in Lung Adenocarcinomas Based on Clinical Testing of 2787 Consecutive Cases
    Dogan, S.
    Brzostowski, E.
    Zakowski, M. F.
    Ladanyi, M.
    LABORATORY INVESTIGATION, 2010, 90 : 401A - 401A
  • [39] Molecular Epidemiology of EGFR and KRAS Mutations in Lung Adenocarcinomas Based on Clinical Testing of 2787 Consecutive Cases
    Dogan, S.
    Brzostowski, E.
    Zakowski, M. F.
    Ladanyi, M.
    MODERN PATHOLOGY, 2010, 23 : 401A - 401A
  • [40] Driver mutations determine survival in smokers and never-smokers with stage IIIB/IV lung adenocarcinomas
    Paik, Paul K.
    Johnson, Melissa L.
    D'Angelo, Sandra P.
    Sima, Camelia S.
    Ang, Daphne
    Dogan, Snjezana
    Miller, Vincent A.
    Ladanyi, Marc
    Kris, Mark G.
    Riely, Gregory J.
    CANCER, 2012, 118 (23) : 5840 - 5847
12345